Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Neurotech International ( (AU:NTI) ) is now available.
Neurotech International has disclosed that Maybank Securities Pte. Ltd. has ceased to be a substantial holder in the company. The notice records that Maybank transferred or otherwise disposed of its relevant interest in 59,597,522 ordinary shares, representing about 4.52% of Neurotech’s voting capital, reducing its ownership below the substantial shareholder threshold and potentially widening the company’s share register.
More about Neurotech International
Neurotech International Ltd is an Australia-listed company focused on neurological technologies and related healthcare solutions. Its shares trade on the ASX under the code NTI, attracting institutional and retail investors active in small- to mid-cap health and biotech names.
Average Trading Volume: 1,489,364
Technical Sentiment Signal: Sell
Current Market Cap: A$16.47M
Find detailed analytics on NTI stock on TipRanks’ Stock Analysis page.